Daktronics Inc. (DAKT) and Travere Therapeutics Inc. (TVTX) are exhibiting notably high options trading volumes today, each representing over 50% of their respective average daily trading volumes. DAKT has seen 1,549 contracts trade, with significant activity in the $17.50 call option expiring September 19, 2025, while TVTX recorded 10,215 contracts, particularly in the $35 call option expiring January 16, 2026. This elevated options activity, especially in specific call strikes, suggests heightened investor interest and potential directional positioning for both equities.
Daktronics (DAKT) and Travere Therapeutics (TVTX) are experiencing significant options market activity, with today's volumes representing 52.1% and 51.3% of their respective average daily share volumes over the past month. This activity is not diffuse but is notably concentrated in specific long-dated call options. For DAKT, a significant portion of its 1,549 contracts traded is in the September 19, 2025, $17.50 strike call. Similarly, TVTX has seen a large part of its 10,215 traded contracts concentrated in the January 16, 2026, $35 strike call. The focus on these specific, long-term call options, rather than a broad increase in volume, suggests that certain market participants are taking a directional view and positioning for significant potential share price appreciation in both companies over the next 18-24 months.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
neutral
Sentiment Score
0.00
Ticker Sentiment
